CHARLES TOWN, W.Va., Sept. 19 /PRNewswire-FirstCall/ -- ReBuilder Medical Technologies Inc. , an emerging medical device manufacturer founded by world renowned medical device inventor David B. Phillips, Ph.D., today announced a joint marketing campaign with firstSTREET (http://www.firstSTREETonline.com), an innovative product catalog company. firstSTREET produces and distributes over 900,000 catalogs annually with sales of $20 million.
(Logo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGO )
“Many of our customers have encouraged us to offer FDA approved consumer oriented medical devices, and the ReBuilder meets the needs of our Baby Boomer customer segment,” said Laura Snarr, VP of Marketing for firstSTREET. “We believe we can distribute many units per month. Our product experts form special relationships with the most innovative manufacturers, so firstSTREET is able to offer their newest products to consumers before they are available in stores. Through our informative catalogs, powerful magazine and newspaper ads and robust website, firstSTREET has become a leader in providing the latest in innovative products to millions of people around the world.”
“We are reaching a new segment of the growing online market with the addition of firstSTREET which we think can expand our customer base by 1.7% translating into a 2.9% increase in profit during 2007,” said David B. Phillips, CEO of ReBuilder Medical Technologies, Inc. “firstSTREET’s niche consists primarily of early adopters, people who like new products and will pay a premium to be the first to acquire them. Reaching these prospects requires identifying them and firstSTREETonline.com specializes in this market. One benefit of this market is the viral marketing aspect. These early adopters usually spread the word about new products to at least 3 others who share their interest in new technology.”
About firstSTREET:
firstSTREET has over 200 employees in Colonial Heights, Virginia. From their knowledgeable product experts to their helpful customer service representatives, firstSTREET uses the best people and the latest technology to create the ultimate customer experience. firstSTREET’s website (http://www.firststreetonline.com) and catalogs are one-stop sources for everything consumers need to take advantage of the newest innovations. Their website features hundreds of products that represent some of the ways today’s innovations can work for anyone. Consumers can find everything they need to know about what our products do, how they work and why they can improve the way you live.
About ReBuilder Medical Technologies, Inc.:
ReBuilder Medical Technologies, Inc is an emerging medical device manufacturer of innovative technologies founded by world renowned medical device inventor David B. Phillips, Ph.D. ReBuilder Medical’s flagship product is its FDA registered, ReBuilder System for treating peripheral neuropathy. Unlike current therapies for neuropathy (nerve disease) which focus on prescription drugs with powerful side effects, the ReBuilder System is a portable, battery powered medical product that provides a new non-surgical treatment which is non-invasive, has no side effects and can actually strengthen muscles while increasing blood flow.
ReBuilder Medical also manufactures the Phillips Molluscum Treatment system for treating the skin disease Molluscum Contagiosum which primarily affects children. This system uses its proprietary form of micronized amorphous silver ions to disable the molluscum virus without side effects. The company is currently performing research and development on a number of other products as well.
Dr. Phillips is CEO of ReBuilder Medical Technologies, Inc. located in Charles Town, WV. He is best known for inventing the very first infrared ear thermometer. Dr. Phillips also was responsible for the GST System for the early detection of breast cancer and the AcuPen which detects acupuncture points and then treats them.
More information on ReBuilder Medical and its products can be found at: http://www.rebuildermedical.com.
Safe Harbor: This letter contains certain forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended and Section 21E of the Securities Exchange Act of 1934, as amended, which are intended to be covered by the safe harbors created thereby. Investors are cautioned that all forward-looking statements involve risks and uncertainty, including without limitation, the ability of the Company to successfully implement its turnaround strategy, changes in costs of raw materials, labor, and employee benefits, as well as general market conditions, competition and pricing. Although the Company believes that the assumptions underlying the forward-looking statements contained herein are reasonable, any of the assumptions could be inaccurate, and therefore, there can be no assurance that the forward-looking statements included in this letter will prove to be accurate. In light of the significant uncertainties inherent in the forward- looking statements included herein, the inclusion of such information should not be regarded as representation by the Company or any other person that the objectives and plans of the Company will be achieved. In assessing forward- looking statements included herein, readers are urged to carefully read those statements. When used in the Annual Report on Form 10-K, the words “estimate,” “anticipate,” “expect,” “believe,” and similar expressions are intended to be forward-looking statements.
Photo: http://www.newscom.com/cgi-bin/prnh/20061128/REBUILDERLOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, photodesk@prnewswire.comReBuilder Medical Technologies, Inc.
CONTACT: Daena Carter of ReBuilder Medical Technologies, Inc.+1-304-725-2202
